Sansure Biotech Overview
- Year Founded
-
2008
- Status
-
Public
- Employees
-
2,128
- Stock Symbol
-
688289
- Investments
-
15
- Share Price
-
$2.25
- (As of Friday Closing)
Sansure Biotech General Information
Description
Sansure Biotech Inc is engaged in the Research, development, production, and sales of diagnostic reagents and instruments.
Contact Information
Website
www.sansure.com.cnCorporate Office
- No. 680, Lusong Road
- Hi-Tech Development Zone
- Changsha, Hunan 410205
- China
Corporate Office
- No. 680, Lusong Road
- Hi-Tech Development Zone
- Changsha, Hunan 410205
- China
Sansure Biotech Stock Performance
As of 13-Nov-2026, Sansure Biotech’s stock price is $2.25. Its current market cap is $1.29B with 575M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.25 | $2.31 | $1.98 - $3.28 | $1.29B | 575M | 5.27M | $0.03 |
Sansure Biotech Financials Summary
As of 30-Sep-2026, Sansure Biotech has a trailing 12-month revenue of $239M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,103,446 | 1,163,867 | 1,260,515 | 946,040 |
| Revenue | 239,350 | 228,266 | 203,201 | 142,351 |
| EBITDA | 5,322 | 45,046 | 46,401 | 67,154 |
| Net Income | 16,200 | 27,664 | 38,408 | 51,410 |
| Total Assets | 1,431,149 | 1,361,596 | 1,178,586 | 1,192,648 |
| Total Debt | 224,585 | 161,121 | 57,924 | 5,405 |
Sansure Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sansure Biotech Patents
Sansure Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026153377-A1 | Quantitative composition, kit, method and use | Pending | 17-Jan-2025 | ||
| WO-2026130573-A1 | Liquefying agent and use thereof, and nucleic acid detection system | Pending | 20-Dec-2024 | ||
| EP-4783174-A1 | Gene sequencing data analysis method and apparatus, computing device and readable storage medium | Pending | 29-Mar-2024 | ||
| WO-2025200669-A1 | Gene sequencing data analysis method and apparatus, computing device and readable storage medium | Pending | 29-Mar-2024 | ||
| US-20260341417-A1 | Gene sequencing data analysis method, computing device, and readable storage medium | Pending | 29-Mar-2024 | G16B50/40 |
Sansure Biotech Signals
Sansure Biotech Investments & Acquisitions (15)
Sansure Biotech’s most recent deal was a Later Stage VC with Zheyuan Technology for . The deal was made on 05-Aug-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Zheyuan Technology | 05-Aug-2026 | Later Stage VC | Decision/Risk Analysis | ||
| inno-train Diagnostik | 29-Jan-2026 | Merger/Acquisition | Diagnostic Equipment | ||
| Hunan Sanway SepSMART | 04-Sep-2025 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| GeneMind | 27-May-2025 | PE Growth/Expansion | Diagnostic Equipment | ||
| ShengWeiKunTeng | 08-May-2025 | Early Stage VC | Diagnostic Equipment |
Sansure Biotech ESG
Risk Overview
Risk Rating
Updated August, 31, 2024
28.45 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,766
Rank
Percentile
Healthcare
Industry
of 581
Rank
Percentile
Medical Devices
Subindustry
of 199
Rank
Percentile
Sansure Biotech Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Hunan Sanway SepSMART | Changsha, China | 2024 | |
| Hygene Biomedicine | Zhongshan, China | 2004 | |
| inno-train Diagnostik | Kronberg, Germany | 1998 |
Sansure Biotech FAQs
-
When was Sansure Biotech founded?
Sansure Biotech was founded in 2008.
-
Where is Sansure Biotech headquartered?
Sansure Biotech is headquartered in Changsha, China.
-
What is the size of Sansure Biotech?
Sansure Biotech has 2,128 total employees.
-
What industry is Sansure Biotech in?
Sansure Biotech’s primary industry is Biotechnology.
-
Is Sansure Biotech a private or public company?
Sansure Biotech is a Public company.
-
What is Sansure Biotech’s stock symbol?
The ticker symbol for Sansure Biotech is 688289.
-
What is the current stock price of Sansure Biotech?
As of 13-Nov-2026 the stock price of Sansure Biotech is $2.25.
-
What is the current market cap of Sansure Biotech?
The current market capitalization of Sansure Biotech is $1.29B.
-
What is Sansure Biotech’s current revenue?
The trailing twelve month revenue for Sansure Biotech is $239M.
-
What is Sansure Biotech’s annual earnings per share (EPS)?
Sansure Biotech’s EPS for 12 months was $0.03.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process